That is a very interesting interpretation. I've owned MNTA since the last time it was in the mid single digits (was that 9 months or 18 months ago, I don't remember) but have only followed it intently from time to time. I don't recall the discussion of the FDA/Teva labeling discussions that happened approximately 6 months ago. Can you refresh my recollection on this press release by Teva?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.